Summary This report studies the Nicotinamide market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Nicotinamide market by product type and applications/end industries. In global market, the production of Nicotinamide increases from 56520 MT in 2012 to 71192 MT in 2016. In 2016, the global Nicotinamide market is led by China, capturing about 37.09% of global Nicotinamide production. Europe is the second-largest region-wise market with31.57% global production share. In 2016, the global Nicotinamide market was valued at 443 million USD. By 2023, the global Nicotinamide market is expected to reach 645 million USD. At present, the major manufacturers of Nicotinamide are concentrated in Lonza, Jubilant Life Sciences, Vertellus, Brother Enterprises, Zhejiang Lanbo Biotechnology, Lasons India,Vanetta, DSM,Tianjin Zhongrui Pharmaceutical and Resonance Specialties . Lonza is the world leader, holding 47.21% production market share in 2016. Lonza’s main markets are China and Europe.Vertellus is the only producer in the United States. At present, Vertellus Europe’s production capacity has been transferred to China. In 2014, Lonza built a new 15,000 production line in China. At the same time, Lonza   Read more…